SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia (BCDA) ®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

Good evening, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals’ First Quarter 2025 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the ...

Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on November 4, 2025. The company will also host a ...

HOUSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (OTCQB:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a ...